Kazakhstan Medical Device Applicant, Authorized Representative and Importer: Roles and Responsibilities

1. Key takeaways

A foreign manufacturer entering Kazakhstan must have three roles in place: an authorized representative (уполномочный представитель) that is a legal entity registered in Kazakhstan, an applicant that bears the submission and fee obligations, and an importer responsible for customs clearance and distribution. The single most important restriction is that only one authorized representative may be designated for a medical device. The name of the authorized representative is written into the registration certificate and into the labelling and instructions for use, and the representative carries post-market contact, adverse event monitoring and regulatory response obligations. Replacing the representative requires official notification and an amendment to the registration certificate; without that amendment the new representative cannot lawfully perform its role. Because all three roles interact with the authorities on the manufacturer’s behalf, gaps or overlaps between them translate directly into compliance risk, and the allocation of duties among them should be documented at project start rather than negotiated informally along the way. Each role also answers to a different body: the applicant interacts with the registration procedure, the representative with post-market supervision, and the importer with customs and traceability systems, so a weakness in any one role surfaces at a different point in the product lifecycle.

2. Legal basis

3. Expert insights

Insight one: one device, one representative, is a hard constraint and the largest commercial risk point. The authorized representative is recorded on the registration certificate. If the manufacturer wishes to change its distribution channel, the incumbent representative must cooperate and sign the consent documents; if the incumbent refuses to cooperate, the manufacturer’s only route is to reapply for registration from the beginning. GRZAN therefore recommends writing the representative’s cooperation obligations and an exit mechanism into the appointment agreement, instead of relying on informal commercial understanding. The agreement should state what the representative must sign, within what reaction time, and what compensation applies if the exit provisions are triggered.

Insight two: the authorized representative carries statutory obligations, not a commercial agency role. Under Order No. ҚР ДСМ-320/2020, post-market monitoring and adverse event related obligations must be assumed by an authorized entity within Kazakhstan. The representative’s real work begins after the certificate is obtained. The selection criterion should therefore be the ability to perform compliance duties over the long term, not the speed of the first dossier submission. A representative with a functioning vigilance team and a track record of answering authority enquiries protects the certificate; a representative chosen only for price creates exposure that surfaces during the first inspection or field safety enquiry.

Insight three: applicant, representative and importer can be separated, but responsibility must not be left vacant. The three roles may be held by different entities: the applicant handles procedure, the representative handles compliance, the importer handles logistics. GRZAN issues a responsibility matrix at project start that assigns every obligation to a specific named entity, eliminating the vacuum in which each party assumes another is acting. The matrix is signed by all parties and revisited whenever any role changes hands. Distributors and tender teams should receive a copy of the matrix as well, because commercial staff who contact the authorities directly on compliance matters create parallel communication lines that later contradict the official record.

Insight four: representative information appears on external documents. The authorized representative must appear on the labels and instructions for use, so a change of representative affects packaging materials already printed. When changing representatives, plan a transition period for packaging stocks in parallel with the certificate amendment; otherwise the market will hold labels that no longer match the registration certificate, which is itself a circulation risk during supervisory checks. Sequencing the amendment, the printed stock run-down and the new stock release in one plan avoids both a compliance gap and an unnecessary write-off of packaging materials, and it gives distributors a clear date from which only updated packs may be shipped.

4. Practical recommendations

1. State the representative’s cooperation obligations, the variation procedure and the exit mechanism in the appointment agreement, together with liability for breach.
2. When selecting a representative, assess long-term capability: whether it maintains a compliance team and whether it can carry adverse event monitoring duties.
3. Issue an applicant / authorized representative / importer responsibility matrix at project start and assign every item to a specific entity.
4. Before replacing a representative, secure the incumbent’s written consent and assess packaging transition arrangements in the same decision.
5. When the representative’s contact details change, process the dossier update promptly so that regulatory notices can always be delivered, and record the change in the distribution documentation at the same time.

5. Verification checklist

• □ The authorized representative is a legal entity registered within Kazakhstan
• □ Only one authorized representative is designated for the device
• □ The appointment agreement contains cooperation obligations, variation procedure and exit mechanism
• □ Representative information is reflected on the labels and instructions for use
• □ The applicant / representative / importer responsibility matrix has been issued and signed
• □ A dossier update process for changes of representative contact details is in place

GRZAN provides registration support in Kazakhstan for manufacturers, importers and authorized representatives, including representation services, responsibility matrix design and dossier variation handling. For assistance, contact info@grzanglobal.com.

Regulatory information verified as of October 29, 2026.